The hope for a new era in Parkinson's treatment: CDNF in focus

The world of medicine may be on the verge of a revolutionary development in the fight against Parkinson's disease, thanks to the discovery and research surrounding a special protein known as Cerebral Dopamine Neurotrophic Factor (CDNF). This development could not only improve the living standards of millions of those affected, but also offer a new way to treat neurodegenerative diseases.

The skin as a mirror of the brain

We all know the skin as the largest organ in our body - it protects us, regulates temperature and enables touch. But did you know that the skin can now also provide insights into the interior of our nervous system? Boston researchers have found that a protein called phosphorylated alpha-synuclein, which plays a key role in Parkinson's disease and other neurodegenerative diseases, can also be detected in the skin. This exciting discovery opens new avenues for diagnosing Parkinson's and related diseases.

Cannabis legalization and Parkinson's disease. Advantages and disadvantages

The discussion about the use of medical cannabis to treat various diseases has increased worldwide in recent years. The potential of cannabis-based therapies is being intensively researched, particularly for Parkinson's disease, a neurodegenerative disease that affects millions of people.

The study of dopamine, serotonin and social behavior

The neurotransmitters dopamine and serotonin in the brain have a significant influence on our social behavior, as new research shows. For the first time, their interaction has been directly observed thanks to the participation of four Parkinson's patients in an experiment during brain surgery. The results reveal a neurochemical mechanism that explains our tendency to make decisions in a social context. Additionally, in the long term, this technique could help to better understand changes in brain chemistry associated with Parkinson's disease.

AI in healthcare: the 10.000 Brains Project

Hypotheses investigated include inflammation, changes in intestinal flora and hygiene factors. Early intervention such as a Mediterranean diet change could reduce the risk of these diseases. Further research is required to clarify the exact connections.

The gut-brain connection: A look at Alzheimer's and Parkinson's

Hypotheses investigated include inflammation, changes in intestinal flora and hygiene factors. Early intervention such as a Mediterranean diet change could reduce the risk of these diseases. Further research is required to clarify the exact connections.

Musk or Messiah? The ethical challenges of Neuralink

Musk or Messiah? The ethical challenges of Neuralink

Elon Musk, the man behind Tesla and SpaceX, has a vision with Neuralink: curing diseases, improving human abilities and ultimately merging humans and machines. But behind the tantalizing promises of healing and progress lurk serious ethical concerns.

Nanoparticles and Parkinson's disease

Plastic waste, especially nanoparticles made from the plastic polystyrene, could influence the development of Parkinson's disease, according to a new study. Researchers found that these tiny plastic particles form a chemical bond with alpha-synuclein, a protein whose deposits in the brain mark the onset of Parkinson's disease.

Quo vadis dPV?

Quo Vadis dPV?

My very personal story
 In 2019 I was surprised by the diagnosis of Parkinson's and anyone who has had this experience knows the feeling of helplessness, panic and uncertainty.

What you need to know about Parkinson's

When a person with Parkinson's or a relative wants to find out about a possible disease, accompanying symptoms play a crucial role. These can affect different parts of the body, including skin, skeleton, sensory organs and psyche. The severity and occurrence of these symptoms vary from person to person, and it is important to note that some symptoms may have other causes.